» Articles » PMID: 33657050

Quercetin Efficiently Alleviates TNF-α-Stimulated Injury by Signal Transducer and Activator of Transcription 1 and Mitogen-Activated Protein Kinase Pathway in H9c2 Cells: A Protective Role of Quercetin in Myocarditis

Overview
Date 2021 Mar 3
PMID 33657050
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to evaluate the protective effect of quercetin and its in-depth mechanism in TNF-α-stimulated cardiomyocytes. The differential expression of TNF-alpha (TNF-α) and signal transducer and activator of transcription 1 (STAT1) was analyzed based on the GEO database. H9c2 cells were stimulated with TNF-α to simulate myocarditis. Cell counting kit-8 assay and flow cytometry assay were performed to detect the cell viability and apoptosis. ELISA was used to measure the levels of proinflammatory cytokines (IL-6 and IL-17A) and anti-inflammatory cytokine (IL-10). STAT1 expression was downregulated by transfection with si-STAT1, and its expression was detected using quantitative real-time polymerase chain reaction and Western blot. Western blot was also performed to assess the expression of the mitogen-activated protein kinase (MAPK) pathway-related factors. In this article, TNF-α was highly expressed in patients with myocarditis, and TNF-α (20 μg/mL) declined the viability of H9c2 cells. Quercetin pretreatment partially alleviated the decrease of cell viability, the increase of apoptosis, and the release of inflammatory cytokines (IL-10, IL-6, and IL-17A) induced by TNF-α. In addition, TNF-α increased STAT1 expression, but quercetin prevented the TNF-α-increased STAT1 level. Remarkably, knockdown of STAT1 enhanced the protective effect of quercetin on TNF-α-injured H9c2 cells. Moreover, quercetin restrained the TNF-α-induced activation of the MAPK pathway. Also, the inhibitory effect of quercetin on the pathway was aggravated by STAT1 lacking. In summing, quercetin plays a protective role in TNF-α-stimulated H9c2 cell injury, which may be related to the regulation of STAT1 and MAPK pathway.

Citing Articles

Network pharmacology and experimental study of Angelica sinensis and Astragalus membranaceus capsules in treating heart failure.

Wu X, Liu A, Lv X, Zhi X, Zeng X, Liu K Heliyon. 2024; 10(20):e38851.

PMID: 39640819 PMC: 11620105. DOI: 10.1016/j.heliyon.2024.e38851.


MicroRNAs in Myocarditis-Review of the Preclinical In Vivo Trials.

Procyk G, Grodzka O, Procyk M, Gasecka A, Gluszek K, Wrzosek M Biomedicines. 2023; 11(10).

PMID: 37893097 PMC: 10604573. DOI: 10.3390/biomedicines11102723.


Identification of the key mechanisms of action of Si-Ni-San in uveitis using bioinformatics and network pharmacology.

Zhang D, Hong L, Zhang R, Zhang Q, Yao J, Wang J Medicine (Baltimore). 2023; 102(34):e34615.

PMID: 37653797 PMC: 10470687. DOI: 10.1097/MD.0000000000034615.


Integrating network pharmacology and experimental validation to decipher the mechanism of action of Jingfang Granule in the treatment of viral myocarditis.

Yao T, Sun B, Li Y, Sun Y, Zhang G, Yue G Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(9):2151-2163.

PMID: 36961551 DOI: 10.1007/s00210-023-02464-y.


Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases.

Zhou P, Ma Y, Zhao X, Hua F Inflammopharmacology. 2023; 31(1):207-220.

PMID: 36609715 DOI: 10.1007/s10787-022-01130-8.